Highline Capital Management, L.P. Adaptive Biotechnologies Corp Transaction History

Highline Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$35.79 - $48.81 $2.04 Million - $2.79 Million	-57,081 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $1.42 Million - $2.76 Million	57,081 New	57,081 $2.76 Million
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $3.67 Million - $6.47 Million	-121,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $4.88 Million - $5.84 Million	121,000 New	121,000 $5.84 Million

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $624M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Highline Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Highline Capital Management, L.P. with notifications on news.